Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U H M Spandau

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 9, 2005
[Vision loss after contusio bulbi]U H M Spandau, G Sauder, J B Jonas
Experimental Eye Research|August 27, 2005
Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathyC A May, A V Ohlmann, H Hammes, et al.
The British Journal of Ophthalmology|June 1, 2005
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivoU H M Spandau, G Sauder, U Schubert, et al.
The British Journal of Ophthalmology|July 19, 2005
Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedemaU H M Spandau, M Derse, P Schmitz-Valckenberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 9, 2005
[Vision loss after contusio bulbi]U H M Spandau, G Sauder, J B Jonas
Experimental Eye Research|August 27, 2005
Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathyC A May, A V Ohlmann, H Hammes, et al.
The British Journal of Ophthalmology|June 1, 2005
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivoU H M Spandau, G Sauder, U Schubert, et al.
The British Journal of Ophthalmology|July 19, 2005
Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedemaU H M Spandau, M Derse, P Schmitz-Valckenberg, et al.
Pageof 1